论文部分内容阅读
为观察肝脏瘤体内注射32P治疗肝动脉化疗栓塞术后对残留的肝癌组织治疗效果。在肝动脉化疗栓塞术后一周，B超引导下在残留的肝脏肿瘤内注射32P。结果肝脏残留肿瘤组织内注射32P后，可使肿瘤进一步缩小，由术前78．6mm±5．2mm缩至42．3mm±7．3mm，P＜0．01，肿瘤液化、坏死。AFP由675．43±162．65μg／L降至68．12±24．23μg／L，P＜0．01。肝动脉血流速度降低有显著性，P＜0．05。结论肝动脉化疗栓塞术和B超引导下肝脏瘤体内注射32P双重介入治疗原发性肝癌效果显著。
In order to observe the effect of intrahepatic injection of 32P intrahepatic arterial chemoembolization on the residual hepatoma tissue. One week after transcatheter arterial chemoembolization, 32P was injected into the residual liver tumor guided by ultrasound. Results After intrahepatic injection of 32P in the residual tumor tissue of the liver, the tumor could be further reduced from 78.6mm±5.2mm preoperatively to 42.3mm±7.3mm, P<0.01. The tumor liquefaction and necrosis. AFP decreased from 675.43±162.65 μg/L to 68.12±24.23 μg/L, P<0.01. The decrease of hepatic arterial blood flow velocity was significant, P<0.05. Conclusion Hepatic arterial chemoembolization and B-ultrasound-guided intrahepatic injection of 32P dual interventional therapy for primary liver cancer have significant effects.